Overview

Lurasidone Low-Dose - High-Dose Study Study

Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the efficacy of lurasidone 20 mg/day in subjects with an acute exacerbation of schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Sunovion
Treatments:
Lurasidone Hydrochloride